Researcher profile · Semantic Scholar

D. Frezzetti

h-index: 14
Works: 26
Citations: 4,611

Most-cited papers

A mammalian microRNA expression atlas based on small RNA library sequencing.
P. Landgraf, M. Rusu, R. Sheridan, Alain Sewer +47 more
2007Cell3,857 citations Open access
Semantic Scholar
VEGF as a potential target in lung cancer
D. Frezzetti, M. Gallo, M. Maiello, A. D'alessio +4 more
2017Expert opinion on therapeutic targets217 citations
Semantic Scholar
Upregulation of miR-21 by Ras in vivo and its role in tumor growth
D. Frezzetti, M. D. Menna, P. Zoppoli, C. Guerra +10 more
2011Oncogene142 citations Open access
Semantic Scholar
Vascular Endothelial Growth Factor A Regulates the Secretion of Different Angiogenic Factors in Lung Cancer Cells
D. Frezzetti, M. Gallo, C. Roma, A. D'alessio +4 more
2016Journal of Cellular Physiology58 citations
Semantic Scholar
The microRNA-Processing Enzyme Dicer Is Essential for Thyroid Function
D. Frezzetti, Carla Reale, G. Calì, L. Nitsch +5 more
2011PLoS ONE55 citations Open access
Semantic Scholar
Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
R. Esposito Abate, D. Frezzetti, M. Maiello, M. Gallo +5 more
2020Cancers42 citations Open access
Semantic Scholar
Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents
A. Rachiglio, M. Lambiase, F. Fenizia, C. Roma +9 more
2019Cancers38 citations Open access
Semantic Scholar
FGFR-targeted therapeutics for the treatment of breast cancer
A. De Luca, D. Frezzetti, M. Gallo, N. Normanno
2017Expert Opinion on Investigational Drugs30 citations
Semantic Scholar
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells
M. Gallo, D. Frezzetti, C. Roma, N. Chicchinelli +6 more
2018OncoTarget26 citations Open access
Semantic Scholar
Selective Dicer Suppression in the Kidney Alters GSK3β/β-Catenin Pathways Promoting a Glomerulocystic Disease
A. Iervolino, F. Trepiccione, Federica Petrillo, M. Spagnuolo +5 more
2015PLoS ONE25 citations Open access
Semantic Scholar
Pharmacokinetic drug evaluation of palbociclib for the treatment of breast cancer
A. De Luca, M. Maiello, A. D'alessio, D. Frezzetti +3 more
2018Expert Opinion on Drug Metabolism & Toxicology21 citations
Semantic Scholar
RNA-seq analysis reveals significant effects of EGFR signalling on the secretome of mesenchymal stem cells
A. De Luca, C. Roma, M. Gallo, F. Fenizia +4 more
2014OncoTarget17 citations Open access
Semantic Scholar
Vandetanib as a potential treatment for breast cancer
A. De Luca, A. D'alessio, M. Maiello, M. Gallo +5 more
2014Expert Opinion on Investigational Drugs17 citations
Semantic Scholar
The potential of monitoring treatment response in non-small cell lung cancer using circulating tumour cells
M. Gallo, A. De Luca, D. Frezzetti, Valeria Passaro +2 more
2019Expert Review of Molecular Diagnostics15 citations
Semantic Scholar
Extracellular matrix proteins as circulating biomarkers for the diagnosis of non-small cell lung cancer patients.
D. Frezzetti, A. De Luca, N. Normanno
2019Journal of Thoracic Disease13 citations Open access
Semantic Scholar
Harmonization of tumor mutation burden testing with comprehensive genomic profiling assays: an IQN Path initiative
R. Esposito Abate, R. Pasquale, A. Sacco, V. Simeon +4 more
2024Journal for ImmunoTherapy of Cancer9 citations Open access
Semantic Scholar
The EGFR Signaling Modulates in Mesenchymal Stem Cells the Expression of miRNAs Involved in the Interaction with Breast Cancer Cells
M. Gallo, Marianeve Carotenuto, D. Frezzetti, R. Camerlingo +4 more
2022Cancers9 citations Open access
Semantic Scholar
Low Impact of Clonal Hematopoiesis on the Determination of RAS Mutations by Cell-Free DNA Testing in Routine Clinical Diagnostics
C. Roma, A. Sacco, L. Forgione, R. Esposito Abate +8 more
2022Diagnostics8 citations Open access
Semantic Scholar
The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells
D. Frezzetti, Vincenza Caridi, L. Marra, Rosa Camerlingo +10 more
2024International Journal of Molecular Sciences5 citations Open access
Semantic Scholar
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood
C. De Rosa, Luisa Amato, Annalisa Ariano, S. Capaldo +18 more
2025The journal of liquid biopsy4 citations Open access
Semantic Scholar
First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial
A. Damato, R. Esposito Abate, S. Tessitore, D. Frezzetti +20 more
2026Nature Communications2 citations Open access
Semantic Scholar
REDAC: RNA-seq expression data analysis chatbot
Giovanni Maria De Filippis, Pranoy Sahu, Pasqualina Ambrosio, S. Picascia +10 more
2025Bioinformatics Advances2 citations
Semantic Scholar
Abstract 4343: Effects of the co-expression of RANTES and IL-6 on the transformed phenotype of breast cancer cells
M. Gallo, D. Frezzetti, N. Normanno, A. De Luca
20171 citations
Semantic Scholar
MiR-23c Regulates the Resistance to Gefitinib in EGFR Mutant Non-Small-Cell Lung Cancer Cells
Brigitta Ignoto, I. Parisi, C. Roma, Rosa Camerlingo +7 more
2026Cells0 citations Open access
Semantic Scholar
2782P Evaluation of TROP2 for immunotherapy response in SCLC along with expression of STING related biomarkers in CTCs
C. De Rosa, L. Amato, S. Capaldo, D. Frezzetti +6 more
2025Annals of Oncology0 citations Open access
Semantic Scholar
Abstract 1509: Transcriptome analysis reveals significant effects of EGFR signaling on the secretome of mesenchymal stem cells.
A. De Luca, C. Roma, F. Fenizia, F. Bergantino +4 more
20130 citations
Semantic Scholar

×8

A. Morabito×3

F. Fenizia×3

Marianeve Carotenuto×3

F. Bergantino×3